ORLANDO - Innventure, Inc. (NASDAQ:INV) announced Wednesday it has closed its previously announced registered direct offering of common stock to four institutional investors, raising approximately $40 million in gross proceeds before deducting offering expenses. The industrial growth conglomerate, currently trading at $3.89 with a market capitalization of $294 million, is slightly undervalued according to InvestingPro Fair Value estimates.
The industrial growth conglomerate plans to use the net proceeds to redeem outstanding convertible debentures and for working capital and general corporate purposes. The company may also exercise its right to receive equity in Accelsius instead of cash for approximately $8 million of intercompany convertible debt and associated interest. This capital infusion comes at a critical time for Innventure, which reported a concerning current ratio of 0.39, indicating short-term obligations exceed liquid assets.
If exercised, this debt would convert into the same series of securities purchased by strategic investors in Accelsius' recently announced $65 million Series B-1 Units sale, which was completed at a post-money valuation of approximately $665 million. InvestingPro data reveals Innventure is quickly burning through cash with an EBITDA of -$110.44 million. Subscribers gain access to 10+ additional ProTips and comprehensive financial metrics that provide deeper insights into Innventure's financial health.
"Our model is built to unlock value from breakthrough technologies, and this capital allows us to advance that mission with even greater conviction," said Bill Haskell, Chief Executive Officer of Innventure. Despite recent financial challenges, analysts remain optimistic, with price targets ranging from $13 to $16, suggesting significant potential upside from current levels.
Titan Partners acted as sole placement agent for the offering, while Northland Capital Markets served as a Capital Markets Advisor.
The offering was made pursuant to an effective shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission on December 23, 2025, and declared effective on January 9, 2026.
Innventure focuses on building companies by commercializing breakthrough technology solutions. The company aims to bridge what it calls the "Valley of Death" between corporate innovation and commercialization through multinational partnerships, operational experience, and scale-up expertise.
This article is based on a press release statement from Innventure, Inc.
In other recent news, Innventure, Inc. has raised approximately $40 million through the sale of common stock to four institutional investors, with Titan Partners acting as the sole placement agent. This offering is expected to close around January 14, 2026, pending customary closing conditions. Additionally, Innventure's subsidiary, Accelsius Holdings LLC, completed a Series B-1 funding round, securing $40 million in total, with significant investments from Legrand DPC, LLC and Johnson Controls, Inc.
In another development, Innventure will be added to the Russell 2000 and Russell 3000 indexes, as well as the Russell Microcap Index, effective December 22, 2025. The company's stockholders recently approved proposals for issuing common stock related to convertible debentures, with a significant majority voting in favor. Furthermore, Innventure has appointed Bruce Brown as its first Lead Independent Director, a move aimed at enhancing corporate governance and board oversight.
This article was generated with the support of AI and reviewed by an editor.